Beginning with the dividend payable in February, 2025. AbbVie (ABBV) is announcing today that its board of directors declared an increase in the company’s quarterly cash dividend from $1.55 per share to $1.64 per share beginning with the dividend payable on February 14, 2025 to shareholders of record as of January 15, 2025. This reflects an increase of approximately 5.8%, continuing AbbVie’s strong commitment to returning cash to shareholders through a growing dividend. Since the company’s inception in 2013, AbbVie has increased its quarterly dividend by 310%.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie reports Q3 adjusted EPS $3.00, consensus $2.91
- AbbVie raises FY24 adjusted EPS view to $10.90-$10.94 from $10.67-$10.87
- AbbVie small cell lung cancer treatment granted FDA orphan designation
- Notable companies reporting before tomorrow’s open
- M&A News: AbbVie (NYSE:ABBV) Will Acquire Aliada Therapeutics for $1.4B